
Waymond D. Bray
Examiner (ID: 831)
| Most Active Art Unit | 3201 |
| Art Unit(s) | 3725, 2899, 3204, 3201, 3203 |
| Total Applications | 3197 |
| Issued Applications | 3049 |
| Pending Applications | 43 |
| Abandoned Applications | 104 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7050719
[patent_doc_number] => 20050186606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Methods and compositions for detecting nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/055849
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4590
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11055849
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/055849 | Methods and compositions for detecting nucleic acids | Feb 10, 2005 | Abandoned |
Array
(
[id] => 5739018
[patent_doc_number] => 20060009409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Double-stranded oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/049636
[patent_app_country] => US
[patent_app_date] => 2005-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 43114
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11049636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/049636 | Double-stranded oligonucleotides | Feb 1, 2005 | Abandoned |
Array
(
[id] => 7233166
[patent_doc_number] => 20050256071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Inhibitor nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/044677
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22971
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11044677
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/044677 | Inhibitor nucleic acids | Jan 26, 2005 | Abandoned |
Array
(
[id] => 5220275
[patent_doc_number] => 20070161586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Drug for preventing and treating atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/586191
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28375
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586191 | Drug for preventing and treating atherosclerosis | Jan 13, 2005 | Abandoned |
Array
(
[id] => 5895415
[patent_doc_number] => 20060003954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis'
[patent_app_type] => utility
[patent_app_number] => 11/021603
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2298
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003954.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021603 | Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis | Dec 20, 2004 | Issued |
Array
(
[id] => 4910438
[patent_doc_number] => 20080021205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Methods and Compositions for Use in Preparing Hairpin Rnas'
[patent_app_type] => utility
[patent_app_number] => 10/581503
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20002
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581503
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581503 | Methods and Compositions for Use in Preparing Hairpin Rnas | Dec 9, 2004 | Abandoned |
Array
(
[id] => 6968884
[patent_doc_number] => 20050235370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Spatiotemporally controlled adult somatic mutagenesis system'
[patent_app_type] => utility
[patent_app_number] => 11/010124
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13613
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20050235370.pdf
[firstpage_image] =>[orig_patent_app_number] => 11010124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/010124 | Spatiotemporally controlled adult somatic mutagenesis system | Dec 8, 2004 | Abandoned |
Array
(
[id] => 7138062
[patent_doc_number] => 20050182012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'NF-kappaB oligonucleotide decoy molecules'
[patent_app_type] => utility
[patent_app_number] => 11/004512
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18069
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20050182012.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004512
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004512 | NF-kappaB oligonucleotide decoy molecules | Dec 1, 2004 | Issued |
Array
(
[id] => 7111203
[patent_doc_number] => 20050208658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'RNA interference mediated inhibition of 11beta hydroxysteriod dehydrogenase-1 (11beta HSD-1) gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/993208
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6118
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208658.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993208
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993208 | RNA interference mediated inhibition of 11beta hydroxysteriod dehydrogenase-1 (11beta HSD-1) gene expression | Nov 18, 2004 | Abandoned |
Array
(
[id] => 5808321
[patent_doc_number] => 20060094676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity'
[patent_app_type] => utility
[patent_app_number] => 10/977376
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19783
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094676.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977376
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977376 | Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity | Oct 28, 2004 | Abandoned |
Array
(
[id] => 7020049
[patent_doc_number] => 20050222068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells'
[patent_app_type] => utility
[patent_app_number] => 10/971959
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12384
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971959
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971959 | Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells | Oct 20, 2004 | Abandoned |
Array
(
[id] => 7019990
[patent_doc_number] => 20050222009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 10/962659
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7139
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222009.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962659
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962659 | Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier | Oct 12, 2004 | Abandoned |
Array
(
[id] => 7083261
[patent_doc_number] => 20050048641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'System and method for delivering polynucleotides to the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 10/962732
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7634
[patent_no_of_claims] => 106
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048641.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962732 | System and method for delivering polynucleotides to the central nervous system | Oct 11, 2004 | Abandoned |
Array
(
[id] => 6939075
[patent_doc_number] => 20050112638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Methods and agents for regulating angiotensin activity'
[patent_app_type] => utility
[patent_app_number] => 10/951091
[patent_app_country] => US
[patent_app_date] => 2004-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15290
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112638.pdf
[firstpage_image] =>[orig_patent_app_number] => 10951091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/951091 | Methods and agents for regulating angiotensin activity | Sep 26, 2004 | Abandoned |
Array
(
[id] => 7129677
[patent_doc_number] => 20050060771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'siRNA encoding constructs and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 10/927962
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10236
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20050060771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10927962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/927962 | siRNA encoding constructs and methods for using the same | Aug 26, 2004 | Abandoned |
Array
(
[id] => 6996659
[patent_doc_number] => 20050136437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Nanoparticles for delivery of nucleic acids and stable double-stranded RNA'
[patent_app_type] => utility
[patent_app_number] => 10/925314
[patent_app_country] => US
[patent_app_date] => 2004-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9000
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136437.pdf
[firstpage_image] =>[orig_patent_app_number] => 10925314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/925314 | Nanoparticles for delivery of nucleic acids and stable double-stranded RNA | Aug 23, 2004 | Abandoned |
Array
(
[id] => 5591427
[patent_doc_number] => 20060040879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Chloroquine coupled nucleic acids and methods for their synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/923112
[patent_app_country] => US
[patent_app_date] => 2004-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31807
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923112 | Chloroquine coupled nucleic acids and methods for their synthesis | Aug 20, 2004 | Abandoned |
Array
(
[id] => 7234416
[patent_doc_number] => 20050079610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/923115
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 64734
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079610.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923115
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923115 | RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA) | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7040449
[patent_doc_number] => 20050159381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/923522
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 75229
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923522 | RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA) | Aug 19, 2004 | Abandoned |
Array
(
[id] => 5590939
[patent_doc_number] => 20060040391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'RNA interference vectors'
[patent_app_type] => utility
[patent_app_number] => 10/922530
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13966
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10922530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/922530 | RNA interference vectors | Aug 19, 2004 | Abandoned |